UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 334

Sortiert nach

The epidemiology of Parkinson's disease: risk factors and prevention

Lancet neurology, 2016-11, Vol.15 (12), p.1257-1272

2016

Link zum Volltext

Verfügbarkeit prüfen

Targeting urate to reduce oxidative stress in Parkinson disease

Experimental neurology, 2017-12, Vol.298 (Pt B), p.210-224

2017

Link zum Volltext

Verfügbarkeit prüfen

Urate as a Marker of Risk and Progression of Neurodegenerative Disease

Neurotherapeutics, 2017-01, Vol.14 (1), p.148-153

2017

Link zum Volltext

Verfügbarkeit prüfen

Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes

Annals of neurology, 2023-09, Vol.94 (3), p.486-501

2023

Link zum Volltext

Verfügbarkeit prüfen

Use of ibuprofen and risk of Parkinson disease

Neurology, 2011-03, Vol.76 (10), p.863

2011

Link zum Volltext

Verfügbarkeit prüfen

Prospective study of plasma urate and risk of Parkinson disease in men and women

Neurology, 2016-02, Vol.86 (6), p.520

2016

Link zum Volltext

Verfügbarkeit prüfen

The sirtuin-2 inhibitor AK7 is neuroprotective in models of Parkinson's disease but not amyotrophic lateral sclerosis and cerebral ischemia

PloS one, 2015-01, Vol.10 (1), p.e0116919

2015

Link zum Volltext

Verfügbarkeit prüfen

Chasing Protection in Parkinson's Disease: Does Exercise Reduce Risk and Progression?

Frontiers in aging neuroscience, 2020-06, Vol.12, p.186-186

2020

Link zum Volltext

Verfügbarkeit prüfen

What to Test in Parkinson Disease Prevention Trials? Repurposed, Low-Risk, and Gene-Targeted Drugs

Neurology, 2022-08, Vol.99 (7 Suppl 1), p.34

2022

Link zum Volltext

Verfügbarkeit prüfen

LRRK2‐Targeting Therapies March Through the Valley of Death

Movement disorders, 2023-03, Vol.38 (3), p.361-365

2023

Link zum Volltext

Verfügbarkeit prüfen

Intake of Flavonoids and Flavonoid-Rich Foods and Mortality Risk Among Individuals With Parkinson Disease: A Prospective Cohort Study

Neurology, 2022-03, Vol.98 (10), p.e1064

2022

Link zum Volltext

Verfügbarkeit prüfen

Adenosine A2A receptor gene disruption protects in an [alpha]-synuclein model of Parkinson's disease

Annals of neurology, 2012-02, Vol.71 (2), p.278

2012

Link zum Volltext

Verfügbarkeit prüfen

Urate and its transgenic depletion modulate neuronal vulnerability in a cellular model of Parkinson's disease

PloS one, 2012-05, Vol.7 (5), p.e37331

2012

Link zum Volltext

Verfügbarkeit prüfen

Physical activity and prodromal features of Parkinson disease

Neurology, 2019-12, Vol.93 (23), p.e2157

2019

Link zum Volltext

Verfügbarkeit prüfen

Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease-Reply

JAMA : the journal of the American Medical Association, 2022-01, Vol.327 (1), p.85

2022

Link zum Volltext

Verfügbarkeit prüfen

Clearing the Smoke: What Protects Smokers from Parkinson's Disease?

Movement disorders, 2024-02, Vol.39 (2), p.267-272

2024

Link zum Volltext

Verfügbarkeit prüfen

Probable Parasomnias and Mortality: A Prospective Study in US Men

Mayo Clinic proceedings, 2023-10, Vol.98 (10), p.1449-1457

2023

Link zum Volltext

Verfügbarkeit prüfen

Higher urate in LRRK2 mutation carriers resistant to Parkinson disease

Annals of neurology, 2019-04, Vol.85 (4), p.593-599

2019

Link zum Volltext

Verfügbarkeit prüfen

Appendectomy and risk of Parkinson's disease in two large prospective cohorts of men and women

Movement disorders, 2018-09, Vol.33 (9), p.1492-1496

2018

Link zum Volltext

Verfügbarkeit prüfen

Lifestyle and Parkinson's disease progression

Movement disorders, 2019-01, Vol.34 (1), p.7-8

2019

Link zum Volltext

Verfügbarkeit prüfen

Do caffeine and more selective adenosine A2A receptor antagonists protect against dopaminergic neurodegeneration in Parkinson's disease?

Parkinsonism & related disorders, 2020-11, Vol.80 (Suppl 1), p.S45-S53

2020

Link zum Volltext

Verfügbarkeit prüfen

Microglia-dependent neuroprotective effects of 4-octyl itaconate against rotenone-and MPP+-induced neurotoxicity in Parkinson’s disease

Scientific reports, 2023-09, Vol.13 (1), p.15539-15539, Article 15539

2023

Link zum Volltext

Verfügbarkeit prüfen

Dietary antioxidants and Parkinson's disease

Movement disorders, 2017-11, Vol.32 (11), p.1501-1503

2017

Link zum Volltext

Verfügbarkeit prüfen

Intake of dairy foods and risk of Parkinson disease

Neurology, 2017-07, Vol.89 (1), p.46

2017

Link zum Volltext

Verfügbarkeit prüfen

Air Pollution and Risk of Parkinson's Disease in a Large Prospective Study of Men

Environmental health perspectives, 2017-08, Vol.125 (8), p.087011-087011

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 334

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(323)
Mit Volltextzugriff
(286)

Publikationsform

Sprache

Englisch
(334)
Japanisch
(48)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The epidemiology of Parkinson's disease: risk factors and prevention

Targeting urate to reduce oxidative stress in Parkinson disease

Urate as a Marker of Risk and Progression of Neurodegenerative Disease

Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes

Use of ibuprofen and risk of Parkinson disease

Prospective study of plasma urate and risk of Parkinson disease in men and women

The sirtuin-2 inhibitor AK7 is neuroprotective in models of Parkinson's disease but not amyotrophic lateral sclerosis and cerebral ischemia

Chasing Protection in Parkinson's Disease: Does Exercise Reduce Risk and Progression?

What to Test in Parkinson Disease Prevention Trials? Repurposed, Low-Risk, and Gene-Targeted Drugs

LRRK2‐Targeting Therapies March Through the Valley of Death

Intake of Flavonoids and Flavonoid-Rich Foods and Mortality Risk Among Individuals With Parkinson Disease: A Prospective Cohort Study

Adenosine A2A receptor gene disruption protects in an [alpha]-synuclein model of Parkinson's disease

Urate and its transgenic depletion modulate neuronal vulnerability in a cellular model of Parkinson's disease

Physical activity and prodromal features of Parkinson disease

Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease-Reply

Clearing the Smoke: What Protects Smokers from Parkinson's Disease?

Probable Parasomnias and Mortality: A Prospective Study in US Men

Higher urate in LRRK2 mutation carriers resistant to Parkinson disease

Appendectomy and risk of Parkinson's disease in two large prospective cohorts of men and women

Lifestyle and Parkinson's disease progression

Do caffeine and more selective adenosine A2A receptor antagonists protect against dopaminergic neurodegeneration in Parkinson's disease?

Microglia-dependent neuroprotective effects of 4-octyl itaconate against rotenone-and MPP+-induced neurotoxicity in Parkinson’s disease

Dietary antioxidants and Parkinson's disease

Intake of dairy foods and risk of Parkinson disease

Air Pollution and Risk of Parkinson's Disease in a Large Prospective Study of Men

Suchergebnisse filtern